Gene · 6672
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer. | Nat Commun | 2026 | 42706241 | PubTator, text mining | PubMed |
| Time-resolved mapping in calves reveals bovine herpesvirus 1 shift from mucosal replication to trigeminal ganglion neuroinvasion with promyelocytic leukemia protein-centered host-virus antagonism. | Microbiol Spectr | 2026 | 42489478 | PubTator, text mining | PubMed |
| Epigenetic regulation of transgenes. | J Biotechnol | 2026 | 42214794 | PubTator, text mining | PubMed |
| Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis. | J Transl Autoimmun | 2026 | 41970282 | PubTator, text mining | PubMed |
| Validation of a Multiparametric, Automated, Macroarray-Based Assay for the Detection of Autoantibodies in Autoimmune Liver Disease. | J Clin Lab Anal | 2026 | 41951558 | PubTator, text mining | PubMed |
| Discovery of novel murine PML isoforms. | Nucleus | 2026 | 41871027 | PubTator, text mining | PubMed |
| Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis. | Ann Gastroenterol | 2026 | 41868880 | PubTator, text mining | PubMed |
| Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis. | Aliment Pharmacol Ther | 2026 | 41845567 | PubTator, text mining | PubMed |
| An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelity. | Nat Cell Biol | 2026 | 41826696 | PubTator, text mining | PubMed |
| Fatigue and circadian rhythm in non-cirrhotic primary biliary cholangitis: An exploratory comparison with primary sclerosing cholangitis and healthy controls. | World J Hepatol | 2026 | 41809483 | PubTator, text mining | PubMed |
| Adult-Onset Diabetes and Liver Fibrosis as Diagnostic Clues to Alström Syndrome: A Case Report. | Cureus | 2026 | 41798557 | PubTator, text mining | PubMed |
| [Positive antinuclear antibodies suggest a high inflammatory burden phenotype: a multicenter retrospective analysis of patients with primary biliary cholangitis]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | 41795975 | PubTator, text mining | PubMed |
| Editorial expression of concern: Role and fate of SP100 protein in response to Rep-dependent nonviral integration system. | Appl Microbiol Biotechnol | 2026 | 41779031 | PubTator, text mining | PubMed |
| HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV. | Nat Commun | 2026 | 41776157 | PubTator, text mining | PubMed |
| ACT001 synergizes with temozolomide-based chemoradiotherapy to cure refractory glioblastoma by targeting TNF-CXCL10-CD8+ T-cell immunity. | Front Pharmacol | 2026 | 41769685 | PubTator, text mining | PubMed |
| Necrotizing Pneumonia in an Elderly Patient With Chronic Obstructive Pulmonary Disease (COPD): A Case Report. | Cureus | 2026 | 41769515 | PubTator, text mining | PubMed |
| PXL: a Nucleic Acid-Binding Module of Promyelocytic Leukemia Protein. | bioRxiv | 2026 | 41756868 | PubTator, text mining | PubMed |
| Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2026 | 41751398 | PubTator, text mining | PubMed |
| Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy. | Signal Transduct Target Ther | 2026 | 41702895 | PubTator, text mining | PubMed |
| Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes. | J Clin Transl Hepatol | 2026 | 41659999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6672/papers